RE:Partnership The new Molecules Division seems like they're better organizing their internal structure. There's no use having pharma/LP's with research questions reaching out to their general sales team.
If someone is commercially partnering on CBD/THC-O-Acetate they'll have no choice but to announce their presence since OILS owns the patent. You can buy oil from anyone, you can only get this molecule from Nextleaf.
This is a ducks-in-a-row move to further operational efficiency.